Clinical Trials Logo

Clinical Trial Summary

This study is being done to identify and differentiate thyroid nodules by acoustic imaging and viscoelastic parameters.


Clinical Trial Description

PRIMARY OBJECTIVES: I. Identification of thyroid nodules by vibro-acoustography - Determine detection rate. II. Evaluate the specificity of VA in differentiating malignant and benign of thyroid nodules - Compare the result to that of ultrasound (US). III. Assess diagnostic value of Shear Wave Ultrasound Vibrometry (SDUV) and Comb Push shear elastography (CUSE) in differentiation of thyroid nodules - correlate SDUV and CUSE results to pathology. IV. Test and compare the results shear wave imaging with new FDA approved ultrasound device called SuperSonic Imagine Aixplorer. V. Assess diagnostic value of Shear Wave Ultrasound Vibrometry (SDUV) and Comb Push shear elastography (CUSE) in differentiation of palpable and sonographically detectable cervical lymph nodes or non-thyroidal neck masses. VI. Assess the diagnostic values of ultrasound quantitative microvessel imaging for differentiation of thyroid nodules and cervical lymph nodes. VII. Assess the response to alcohol ablation on patients with recurrent thyroid cancer on thyroid bed or new lymph nodes on neck. OUTLINE: This is an observational study. Patients undergo ultrasound imaging on study. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06207188
Study type Observational
Source Mayo Clinic
Contact
Status Recruiting
Phase
Start date May 17, 2009
Completion date December 31, 2026

See also
  Status Clinical Trial Phase
Recruiting NCT04593277 - Interactive Survivorship Program for the Improvement of Healthcare Resources in Adolescent and Young Adult Cancer Survivors, INSPIRE-AYA Study N/A
Recruiting NCT05229341 - Evaluation of DNA Methylation Signatures for the Diagnosis and Management of Thyroid Nodules N/A
Not yet recruiting NCT03510143 - Effect of Polyglycolic Acid Mesh (Neoveil) in Thyroid Cancer Surgery N/A
Terminated NCT03463889 - Gallium-68 Prostate Specific Membrane Antigen PET in Diagnosing Patients With Thyroid Cancer Phase 2
Active, not recruiting NCT02834013 - Nivolumab and Ipilimumab in Treating Patients With Rare Tumors Phase 2
Suspended NCT04742608 - Development of Liquid Biopsy Technologies for Noninvasive Cancer Diagnostics in Patients With Suspicious Thyroid Nodules or Thyroid Cancer
Completed NCT02713269 - Thermal Ablation and Spine Stereotactic Radiosurgery in Treating Patients With Spine Metastases at Risk for Compressing the Spinal Cord Phase 2
Recruiting NCT04459273 - Prospective Exploratory Study of FAPi PET/CT With Histopathology Validation in Patients With Various Cancers Phase 1
Active, not recruiting NCT02465060 - Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial) Phase 2
Recruiting NCT04589624 - An Investigational Scan (hpMRI) for Monitoring Treatment Response in Patients With Thyroid Cancer and Other Malignancies of the Head and Neck Undergoing Radiation Therapy and/or Systemic Therapy Phase 1
Recruiting NCT05334069 - Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Terminated NCT02062632 - Doxepin Hydrochloride in Treating Esophageal Pain in Patients With Thoracic Cancer Receiving Radiation Therapy to the Thorax With or Without Chemotherapy Phase 2